Literature DB >> 20485326

Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements.

Annabel Whibley1, Jill Urquhart, Jonathan Dore, Lionel Willatt, Georgina Parkin, Lorraine Gaunt, Graeme Black, Dian Donnai, F Lucy Raymond.   

Abstract

Monoamine oxidases (MAO-A and MAO-B) have a key role in the degradation of amine neurotransmitters, such as dopamine, norepinephrine and serotonin. We identified an inherited 240 kb deletion on Xp11.3-p11.4, which encompasses both monoamine oxidase genes but, unlike other published reports, does not affect the adjacent Norrie disease gene (NDP). The brothers who inherited the deletion, and thus have no monoamine oxidase function, presented with severe developmental delay, intermittent hypotonia and stereotypical hand movements. The clinical features accord with published reports of larger microdeletions and selective MAO-A and MAO-B deficiencies in humans and mouse models and suggest considerable functional compensation between MAO-A and MAO-B under normal conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485326      PMCID: PMC2987451          DOI: 10.1038/ejhg.2010.41

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

1.  NDP gene mutations in 14 French families with Norrie disease.

Authors:  Ghislaine Royer; Sylvain Hanein; Valérie Raclin; Nadine Gigarel; Jean-Michel Rozet; Arnold Munnich; Julie Steffann; Jean-Louis Dufier; Josseline Kaplan; Jean-Paul Bonnefont
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

2.  Norrie's disease. A congenital progressive oculo-acoustico-cerebral degeneration.

Authors:  M Warburg
Journal:  Acta Ophthalmol (Copenh)       Date:  1966

3.  Two Thai families with Norrie disease (ND): association of two novel missense mutations with severe ND phenotype, seizures, and a manifesting carrier.

Authors:  K Yamada; P Limprasert; M Ratanasukon; S Tengtrisorn; J Yingchareonpukdee; P Vasiknanonte; T Kitaoka; M Ghadami; N Niikawa; T Kishino
Journal:  Am J Med Genet       Date:  2001-04-15

4.  Mutations in EFHC1 cause juvenile myoclonic epilepsy.

Authors:  Toshimitsu Suzuki; Antonio V Delgado-Escueta; Kripamoy Aguan; Maria E Alonso; Jun Shi; Yuji Hara; Motohiro Nishida; Tomohiro Numata; Marco T Medina; Tamaki Takeuchi; Ryoji Morita; Dongsheng Bai; Subramaniam Ganesh; Yoshihisa Sugimoto; Johji Inazawa; Julia N Bailey; Adriana Ochoa; Aurelio Jara-Prado; Astrid Rasmussen; Jaime Ramos-Peek; Sergio Cordova; Francisco Rubio-Donnadieu; Yushi Inoue; Makiko Osawa; Sunao Kaneko; Hirokazu Oguni; Yasuo Mori; Kazuhiro Yamakawa
Journal:  Nat Genet       Date:  2004-07-18       Impact factor: 38.330

5.  A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior.

Authors:  Kevin Chen; Daniel P Holschneider; Weihua Wu; Igor Rebrin; Jean C Shih
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

6.  Norrie disease resulting from a gene deletion: clinical features and DNA studies.

Authors:  D Donnai; R C Mountford; A P Read
Journal:  J Med Genet       Date:  1988-02       Impact factor: 6.318

7.  Submicroscopic interstitial deletion of the X chromosome explains a complex genetic syndrome dominated by Norrie disease.

Authors:  A Gal; B Wieringa; D F Smeets; L Bleeker-Wagemakers; H H Ropers
Journal:  Cytogenet Cell Genet       Date:  1986

8.  Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease.

Authors:  N C Lan; C Heinzmann; A Gal; I Klisak; U Orth; E Lai; J Grimsby; R S Sparkes; T Mohandas; J C Shih
Journal:  Genomics       Date:  1989-05       Impact factor: 5.736

Review 9.  Organization of MAO A and MAO B promoters and regulation of gene expression.

Authors:  Kevin Chen
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

Review 10.  Monoamine oxidase expression during development and aging.

Authors:  Antonietta Nicotra; Federica Pierucci; Hasan Parvez; Ornella Senatori
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  21 in total

1.  Duplication of MAOA, MAOB, and NDP in a patient with mental retardation and epilepsy.

Authors:  Laura L Klitten; Rikke S Møller; Kirstine Ravn; Helle Hjalgrim; Niels Tommerup
Journal:  Eur J Hum Genet       Date:  2010-09-01       Impact factor: 4.246

Review 2.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

3.  De novo microdeletion of Xp11.3 exclusively encompassing the monoamine oxidase A and B genes in a male infant with episodic hypotonia: a genomics approach to personalized medicine.

Authors:  Ryan E O'Leary; Jean C Shih; Keith Hyland; Nancy Kramer; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-02-03       Impact factor: 2.708

Review 4.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

5.  A novel contiguous deletion involving NDP, MAOB and EFHC2 gene in a patient with familial Norrie disease: bilateral blindness and leucocoria without other deficits.

Authors:  Bei Jia; Liping Huang; Yaoyu Chen; Siping Liu; Cuihua Chen; Ke Xiong; Lanlin Song; Yulai Zhou; Xinping Yang; Mei Zhong
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

6.  Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability.

Authors:  Annabel C Whibley; Vincent Plagnol; Patrick S Tarpey; Fatima Abidi; Tod Fullston; Maja K Choma; Catherine A Boucher; Lorraine Shepherd; Lionel Willatt; Georgina Parkin; Raffaella Smith; P Andrew Futreal; Marie Shaw; Jackie Boyle; Andrea Licata; Cindy Skinner; Roger E Stevenson; Gillian Turner; Michael Field; Anna Hackett; Charles E Schwartz; Jozef Gecz; Michael R Stratton; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2010-07-22       Impact factor: 11.025

7.  Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice.

Authors:  Chanpreet Singh; Marco Bortolato; Namrata Bali; Sean C Godar; Anna L Scott; Kevin Chen; Richard F Thompson; Jean C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 8.  Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Authors:  Marco Bortolato; Jean C Shih
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

9.  Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans.

Authors:  M A Fox; M G Panessiti; P R Moya; T J Tolliver; K Chen; J C Shih; D L Murphy
Journal:  Pharmacogenomics J       Date:  2012-09-11       Impact factor: 3.550

10.  Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice.

Authors:  R Ye; A M D Carneiro; D Airey; E Sanders-Bush; R W Williams; L Lu; J Wang; B Zhang; R D Blakely
Journal:  Genes Brain Behav       Date:  2013-10-31       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.